Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Revolution Medicines, Inc. RVMDW

Full chart Compare
Set alert

Price alert · RVMDW

All alert types
9.90 USD +1.25 (+14.38%)

Nov 6, 2026, 3:59 PM EST

9.19 Day range 10.01
9.90 52-week range 9.90
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

12.79 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 4

Valuation

P/E -13.4×
FY 2017: -34.0×FY 2018: -25.1×FY 2019: -22.1×FY 2020: -24.4×FY 2021: -10.2×FY 2022: -7.7×FY 2023: -7.4×FY 2024: -12.2×FY 2025: -13.4×
FY 2017 5y median -10.2× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 52.3×FY 2019: 21.1×FY 2020: 61.3×FY 2021: 62.4×FY 2022: 54.3×FY 2023: 280×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 54.3× FY 2025
P/B 9.3×
FY 2017: 233×FY 2018: 10.9×FY 2019: 6.9×FY 2020: 5.6×FY 2021: 3.0×FY 2022: 2.8×FY 2023: 1.8×FY 2024: 3.2×FY 2025: 9.3×
FY 2017 5y median 3.0× FY 2025
P/FCF -16.6×
FY 2017: -39.4×FY 2018: -3686×FY 2019: -20.2×FY 2020: -25.6×FY 2021: -11.9×FY 2022: -8.2×FY 2023: -9.1×FY 2024: -12.9×FY 2025: -16.6×
FY 2017 5y median -11.9× FY 2025
EV/EBITDA -13.7×
FY 2017: -35.0×FY 2018: -24.7×FY 2019: -21.4×FY 2020: -25.2×FY 2021: -10.0×FY 2022: -7.6×FY 2023: -6.1×FY 2024: -11.8×FY 2025: -13.7×
FY 2017 5y median -10.0× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 48.8×FY 2019: 20.7×FY 2020: 59.7×FY 2021: 60.9×FY 2022: 51.5×FY 2023: 228×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 51.5× FY 2025
FCF Yield -6.0%
FY 2017: -2.5%FY 2018: -0.0%FY 2019: -5.0%FY 2020: -3.9%FY 2021: -8.4%FY 2022: -12.2%FY 2023: -11.0%FY 2024: -7.7%FY 2025: -6.0%
FY 2017 5y median -8.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: -200.0%FY 2019: -108.2%FY 2020: -257.5%FY 2021: -639.7%FY 2022: -730.0%FY 2023: -4207.1%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median -639.7% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: -207.2%FY 2019: -95.2%FY 2020: -251.6%FY 2021: -636.6%FY 2022: -703.0%FY 2023: -3768.3%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median -636.6% FY 2025
ROE -69.3%
FY 2017: -687.0%FY 2018: -43.2%FY 2019: -31.2%FY 2020: -22.8%FY 2021: -31.0%FY 2022: -36.3%FY 2023: -23.9%FY 2024: -26.5%FY 2025: -69.3%
FY 2017 5y median -31.0% FY 2025
ROIC -56.8%
FY 2017: -416.2%FY 2018: -28.8%FY 2019: -27.9%FY 2020: -21.1%FY 2021: -27.5%FY 2022: -34.1%FY 2023: -25.1%FY 2024: -28.6%FY 2025: -56.8%
FY 2017 5y median -28.6% FY 2025
ROA -48.0%
FY 2017: -206.5%FY 2018: -24.5%FY 2019: -21.6%FY 2020: -19.1%FY 2021: -25.4%FY 2022: -30.6%FY 2023: -21.2%FY 2024: -23.5%FY 2025: -48.0%
FY 2017 5y median -25.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 148.2%FY 2020: -14.1%FY 2021: -31.6%FY 2022: 20.4%FY 2023: -67.3%FY 2024: -100.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -71.5%
FY 2017: 0.0%FY 2018: -29.6%FY 2019: -34.2%FY 2020: -104.5%FY 2021: -69.8%FY 2022: -37.4%FY 2023: -88.6%FY 2024: -41.5%FY 2025: -71.5%
FY 2017 FY 2025
EPS (diluted) -66.2%
FY 2017: 0.0%FY 2018: -35.3%FY 2019: -13.9%FY 2020: -23.7%FY 2021: -52.5%FY 2022: -24.7%FY 2023: -25.3%FY 2024: 7.3%FY 2025: -66.2%
FY 2017 FY 2025
Free Cash Flow -60.9%
FY 2017: 0.0%FY 2018: 98.9%FY 2019: -18153.5%FY 2020: -97.3%FY 2021: -49.2%FY 2022: -53.0%FY 2023: -52.3%FY 2024: -58.5%FY 2025: -60.9%
FY 2017 FY 2025

Financial Health

Current Ratio 7.1×
FY 2017: 1.2×FY 2018: 2.8×FY 2019: 3.1×FY 2020: 9.6×FY 2021: 9.8×FY 2022: 10.7×FY 2023: 13.1×FY 2024: 14.2×FY 2025: 7.1×
FY 2017 5y median 10.7× FY 2025
Quick Ratio 7.1×
FY 2017: 1.2×FY 2018: 2.6×FY 2019: 3.1×FY 2020: 9.6×FY 2021: 9.8×FY 2022: 10.7×FY 2023: 13.1×FY 2024: 14.2×FY 2025: 7.1×
FY 2017 5y median 10.7× FY 2025
Debt / Equity 0.1×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.1×
FY 2017 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2017: 0.3×FY 2018: 1.7×FY 2019: 0.3×FY 2020: 0.7×FY 2021: 0.2×FY 2022: 0.4×FY 2023: 1.4×FY 2024: 0.7×FY 2025: 0.2×
FY 2017 5y median 0.4× FY 2025
Interest Coverage -48.8×
FY 2017: -302×FY 2018: -348×FY 2019: -511×FY 2020: -1559×FY 2021: -15667×FY 2022: 0.0×FY 2023: -1608×FY 2024: 0.0×FY 2025: -48.8×
FY 2017 5y median -48.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31